|
(MoneyNewsWire.Net, November 21, 2017 ) According to the report Europe Biosimilars Market, published by Market DataForecast, the global market is projected to reach USD 7.37 billionby 2021, at a CAGR of 33% from 2016 to 2021.
Get accurate market forecast and analysis on the Europe BiosimilarsMarket. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/request-sample
Biosimilarsare made using living cells that treat disease, by recombinant DNA technology and controlled gene expression. Most biosimilars are derived from bacteria, viruses, plants and animals. Biosimilar drugs are used in prevention and cure of various diseases such as rheumatoid arthritis, cancer, chronic kidney failure, oncology, diabetes, heart attacks, autoimmune diseases, growth hormone deficiency, and infectious disease.
Biosimilars are rapidly growing as one of the most important sectors in the healthcare industry. With increasing healthcare costs, biosimilarsare being looked upon as an affordable treatment option. Growing economies are observing comprehensive growth in biosimilars industry from demanding clinical needs of therapeutics. Rise in GDP and healthcare expenditures, and the demand for cost effective therapeutics solution has resulted in the growth of this market.
Get a comprehensive overview of the Europe Biosimilars Market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/
Europe BiosimilarsMarket: Drivers & Restraints
Biosimilars offer a cheaper alternative for other biological and synthetic drugs. Across the world, the biosimilars market is driven by aging population and increasing rates of diabetes and chronic disorders. However, high manufacturing cost and complexity, and the availability of low priced generic drugs in the market are some of the major restraints of biosimilars market are facing.
Europe BiosimilarsMarket: Segmentation
By Type
• Protein
• Insulin
• Human Growth Hormones
• Granulocyte Colony-stimulating Factor (G-CSF)
• Interferons
• Recombinant Glycosylated Proteins
• Erythropoietin
• Monoclonal Antibodies
• Follitropin
• Recombinant Peptides
• Glucagon
• Calcitonin
By Technology
• Mass Spectroscopy
• Chromatography
• Monoclonal Antibody Technology
• Recombinant DNA Technology
• Nuclear magnetic resonance (NMR) technology
• Electrophoresis
• Bioassay
By Application
• Oncology diseases
• Blood disorders
• Growth hormone deficiencies
• Chronic and autoimmune diseases
• Others
Fromsimple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/customize-report
Europe BiosimilarsMarket: Overview
Most existing drugs are expected to lose their EU patents by 2020, including leading treatments for breast cancer, diabetes and rheumatoid arthritis. Overall, the opportunities in biosimilar research are expected to escalate throughout Europe.Government support and initiatives play a crucial role. Emerging pharmaceutical markets and lenient government regulations provide some of the major openings this is market. Economic turmoil in Europe is another factor which adds to the demand for biosimilars market.
EuropeBiosimilarsMarket: Region-wise Outlook
Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France. Europe dominates the biosimilar market. In the coming years, several new classes of biosimilarsare expected to be submitted for approval in Europe.
Key Questions Answered
• What are the major players in this industry and the key strategies adopted by them to sustain and grow in the studiedEuropemarket ?
• What is the current and future BiosimilarsMarket outlook in Europe? What trends are affecting the Global market?
• What is the competitive landscape and market share of major players in the Biosimilarsspace in Europe?
• What are the key, high growth markets that Biosimilarsmanufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Biosimilarscurrently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Biosimilars?
• What are the challenges and barriers that have hindered widespread adoption of Biosimilars?
Europe BiosimilarsMarket: Key Players
Some of the major players in the biosimilars market are Sandoz International GmbH, Wockhardt Ltd, Hospira, Inc., Teva Pharmaceutical Industries Ltd. Dr. Reddy’s Laboratories, Biocon Limited, Mylan, Inc., ZydusCadila, Celltrion Inc., Roche Diagnostics and Cipla Ltd.
Reasons to buy Europe BiosimilarsMarketReport:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
•Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Europe Antivenom Market: http://www.marketdataforecast.com/market-reports/europe-antivenom-market-1582/
Europe Regenerative Medicines Market: http://www.marketdataforecast.com/market-reports/europe-regenerative-medicines-market-274/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
